T-CEPTOR
Live / Registered — Registered (as of 11 Feb 2025)
What this means for you
Registered since 11 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98081098
- Registration number
- 7683956
- Mark type
- Stylized text
- Filed
- 12 Jul 2023
- Published for opposition
- 24 Dec 2024
- Registered
- 11 Feb 2025
- Attorney of record
- Stacy J. Grossman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical and biological pharmaceutical preparations for medical purposes, namely, for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; immunotherapeutic drugs namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; industrial analysis and industrial research services in the field of pharmaceuticals and genome engineering; research in the field of DNA repair technology; design and development of computer hardware and software; genetic microbiology and microbiome research for scientific research purposes; scientific research in the field of genetics and genetic engineering; clinical research in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering for protection and prevention from infections, cancer, disease or inflammation; scientific research in the nature of conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of microorganisms and cells in the nature of guided nuclease-based biocides; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; bacteriological research; scientific research for medical purposes in the field of viruses and viral diseases; biological research; scientific screening and assaying being drug screening for scientific research purposes; chemical analysis; chemical research; DNA screening for scientific research purposes; genetic testing of laboratory animals for research purposes; biochemical engineering services being biochemical research and development; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the field of pharmaceuticals and scientific research consulting in the field of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes
Owner
- T-Therapeutics Limited, Cambridge, GB
- T-Therapeutics Limited, Cambridge, GB
- T-Therapeutics Limited, Cambridge, GB
Prosecution history
- 28 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2024 — PUBLISHED FOR OPPOSITION
- 18 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 22 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 22 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN